CLBT Cellebrite DI Ltd.
Technology$13.18+0.00%OpenMarket Cap: $3.29B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$19.67
Target (Median)
$21.00
Target Range
$15.00 - $23.00
Upside from current price: 49.3%
Rating Distribution
2 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Needham | maintain | Buy | Buy |
| 2026-02-12 | Needham | maintain | Buy | Buy |
| 2025-11-13 | B of A Securities | maintain | Buy | Buy |
| 2025-11-13 | Needham | maintain | Buy | Buy |
| 2025-11-13 | JP Morgan | maintain | Overweight | Overweight |
| 2025-11-13 | Lake Street | maintain | Buy | Buy |
| 2025-09-24 | JP Morgan | maintain | Overweight | Overweight |
| 2025-08-15 | Lake Street | maintain | Buy | Buy |
| 2025-08-14 | Needham | maintain | Buy | Buy |
| 2025-06-23 | JP Morgan | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $0.33 | $567.8M | 5 |
| Fri Dec 31 | $0.44 | $667.5M | 4 |
| Sun Dec 31 | $0.57 | $783.2M | 2 |
| Mon Dec 31 | $0.91 | $864.7M | 1 |